Tetra Bio Pharma to begin in-life trial for its CBD-based cancer pain drug QIXLEEF

Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) VP of Clinical Operations Aurelia De Pauw tells Proactive the group is beginning the in-life phase of its …

Be the first to comment

Leave a Reply

Your email address will not be published.